WT1 gene expression: Useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?

Peter Bader, Charlotte Niemeyer, Gerrit Weber, Tiziana Coliva, Vincenzo Rossi, Hermann Kreyenberg, Anja Gerecke, Andrea Biondi

Research output: Contribution to journalArticle

Abstract

The WT1 gene is considered to be highly expressed in patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia and chronic myeloid leukemia and is thought to play a key role in maintaining the viability of leukemia cells. However, little is known about the WT1 gene expression levels in pediatric patients with juvenile myelo-monocytic leukemia (JMML) and myelodysplastic syndromes (MDS). We studied WT1 expression in diagnostic bone marrow (BM) and peripheral blood (PB) samples of 90 patients with JMML, low grade MDS, advanced MDS and myelodysplasia-related AML in BM (n = 20) and PB (n = 18) samples of normal healthy volunteer donors.

Original languageEnglish
Pages (from-to)25-28
Number of pages4
JournalEuropean Journal of Haematology
Volume73
Issue number1
DOIs
Publication statusPublished - Jul 2004

Fingerprint

Myelodysplastic Syndromes
Residual Neoplasm
Leukemia
Gene Expression
Acute Myeloid Leukemia
Healthy Volunteers
Bone Marrow
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Cell Survival
Tissue Donors
Pediatrics
Genes

Keywords

  • Childhood
  • Juvenile myelo-monocytic leukemia
  • Minimal residual disease
  • Myelodysplastic syndromes
  • WT1 gene expression

ASJC Scopus subject areas

  • Hematology

Cite this

WT1 gene expression : Useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia? / Bader, Peter; Niemeyer, Charlotte; Weber, Gerrit; Coliva, Tiziana; Rossi, Vincenzo; Kreyenberg, Hermann; Gerecke, Anja; Biondi, Andrea.

In: European Journal of Haematology, Vol. 73, No. 1, 07.2004, p. 25-28.

Research output: Contribution to journalArticle

Bader, Peter ; Niemeyer, Charlotte ; Weber, Gerrit ; Coliva, Tiziana ; Rossi, Vincenzo ; Kreyenberg, Hermann ; Gerecke, Anja ; Biondi, Andrea. / WT1 gene expression : Useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?. In: European Journal of Haematology. 2004 ; Vol. 73, No. 1. pp. 25-28.
@article{6f7f67e44fd84e379e6c7f9ce7196c44,
title = "WT1 gene expression: Useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?",
abstract = "The WT1 gene is considered to be highly expressed in patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia and chronic myeloid leukemia and is thought to play a key role in maintaining the viability of leukemia cells. However, little is known about the WT1 gene expression levels in pediatric patients with juvenile myelo-monocytic leukemia (JMML) and myelodysplastic syndromes (MDS). We studied WT1 expression in diagnostic bone marrow (BM) and peripheral blood (PB) samples of 90 patients with JMML, low grade MDS, advanced MDS and myelodysplasia-related AML in BM (n = 20) and PB (n = 18) samples of normal healthy volunteer donors.",
keywords = "Childhood, Juvenile myelo-monocytic leukemia, Minimal residual disease, Myelodysplastic syndromes, WT1 gene expression",
author = "Peter Bader and Charlotte Niemeyer and Gerrit Weber and Tiziana Coliva and Vincenzo Rossi and Hermann Kreyenberg and Anja Gerecke and Andrea Biondi",
year = "2004",
month = "7",
doi = "10.1111/j.1600-0609.2004.00260.x",
language = "English",
volume = "73",
pages = "25--28",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - WT1 gene expression

T2 - Useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?

AU - Bader, Peter

AU - Niemeyer, Charlotte

AU - Weber, Gerrit

AU - Coliva, Tiziana

AU - Rossi, Vincenzo

AU - Kreyenberg, Hermann

AU - Gerecke, Anja

AU - Biondi, Andrea

PY - 2004/7

Y1 - 2004/7

N2 - The WT1 gene is considered to be highly expressed in patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia and chronic myeloid leukemia and is thought to play a key role in maintaining the viability of leukemia cells. However, little is known about the WT1 gene expression levels in pediatric patients with juvenile myelo-monocytic leukemia (JMML) and myelodysplastic syndromes (MDS). We studied WT1 expression in diagnostic bone marrow (BM) and peripheral blood (PB) samples of 90 patients with JMML, low grade MDS, advanced MDS and myelodysplasia-related AML in BM (n = 20) and PB (n = 18) samples of normal healthy volunteer donors.

AB - The WT1 gene is considered to be highly expressed in patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia and chronic myeloid leukemia and is thought to play a key role in maintaining the viability of leukemia cells. However, little is known about the WT1 gene expression levels in pediatric patients with juvenile myelo-monocytic leukemia (JMML) and myelodysplastic syndromes (MDS). We studied WT1 expression in diagnostic bone marrow (BM) and peripheral blood (PB) samples of 90 patients with JMML, low grade MDS, advanced MDS and myelodysplasia-related AML in BM (n = 20) and PB (n = 18) samples of normal healthy volunteer donors.

KW - Childhood

KW - Juvenile myelo-monocytic leukemia

KW - Minimal residual disease

KW - Myelodysplastic syndromes

KW - WT1 gene expression

UR - http://www.scopus.com/inward/record.url?scp=3042663013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042663013&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0609.2004.00260.x

DO - 10.1111/j.1600-0609.2004.00260.x

M3 - Article

C2 - 15182334

AN - SCOPUS:3042663013

VL - 73

SP - 25

EP - 28

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 1

ER -